Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Reumatología | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Terminado
Fase 2
ClinicalTrials.gov
Multi-Centre Randomised Double-Blind Pbo-Controlled Dose-Ranging Study to Evaluate the Safety, Tolerability, Efficacy, PK and Immunogenicity of Multiple Doses of ART621 for 3 Months in Patients With Rheumatoid Arthritis Taking Methotrexate
INTERVENTIONAL
Inicio: 1 de abr de 2009
ID: NCT00928317
Completado
Fase 2
ClinicalTrials.gov
A Randomized, Parallel Group, Double-Blind, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of BMS-582949 Given Orally to Subjects With Rheumatoid Arthritis Having an Inadequate Response to Methotrexate
INTERVENTIONAL
Inicio: 1 de mar de 2008
ID: NCT00605735
Desconocido
ClinicalTrials.gov
ACR/EULAR Endorsed Study to Develop New Diagnostic and Classification Criteria for Primary Systemic Vasculitis
OBSERVATIONAL
Inicio: 1 de ene de 2011
ID: NCT01066208
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double-blind, Parallel, Placebo-controlled Study Assessing the Efficacy and Safety of Sarilumab Added to Non-biologic DMARD Therapy in Patients With Rheumatoid Arthritis Who Are Inadequate Responders to or Intolerant of TNF-α Antagonists
INTERVENTIONAL
Inicio: 1 de oct de 2012
ID: NCT01709578
Reclutando
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Belimumab Administered Subcutaneously in Adults With Interstitial Lung Disease (ILD) Associated With Connective Tissue Disease (CTD)
INTERVENTIONAL
Inicio: 11 de sept de 2024
ID: NCT06572384
Terminado
Fase 3
ClinicalTrials.gov
A Multi-centre Long-term Extension Study to Assess the Safety and Efficacy of GSK3196165 in the Treatment of Rheumatoid Arthritis
INTERVENTIONAL
Inicio: 12 de may de 2020
ID: NCT04333147
Completado
Fase 3
ClinicalTrials.gov
Phase 3, Multicenter, Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Subjects With Adult-Onset Active and Progressive Psoriatic Arthritis (PsA)
INTERVENTIONAL
Inicio: 1 de mar de 2010
ID: NCT01087788
Terminado
Fase 3
ClinicalTrials.gov
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Ustekinumab in Subjects With Active Systemic Lupus Erythematosus
INTERVENTIONAL
Inicio: 16 de abr de 2018
ID: NCT03517722
Terminado
Fase 2
ClinicalTrials.gov
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Phase II Study to Evaluate The Safety and Efficacy of RO7123520 as Adjunct Treatment in Patients With Moderately to Severely Active Rheumatoid Arthritis and an Inadequate Response to TNF-alpha Inhibitors
INTERVENTIONAL
Inicio: 22 de dic de 2016
ID: NCT03001219
Completado
Fase 2
ClinicalTrials.gov
A Randomized, Placebo Controlled, Investigator and Participant-blinded Study Investigating Safety, Tolerability, and Efficacy of RHH646 in Participants With Knee Osteoarthritis
INTERVENTIONAL
Inicio: 31 de may de 2023
ID: NCT05816395
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Double-Blind, Study Comparing Risankizumab to Placebo in Subjects With Active Psoriatic Arthritis (PsA) Who Have a History of Inadequate Response to or Intolerance to at Least One Disease Modifying Anti-Rheumatic Drug (DMARD) Therapy (KEEPsAKE 1)
INTERVENTIONAL
Inicio: 25 de mar de 2019
ID: NCT03675308
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double-blind Study of Safety and Reduction in Signs and Symptoms During Treatment With Tocilizumab Monotherapy Versus Methotrexate Monotherapy in Patients With Moderate to Severe Active Rheumatoid Arthritis
INTERVENTIONAL
Inicio: 1 de jul de 2005
ID: NCT00109408
Completado
Fase 3
ClinicalTrials.gov
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Golimumab, an Anti-TNFalpha Monoclonal Antibody, Administered Intravenously, in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy
INTERVENTIONAL
Inicio: 1 de sept de 2009
ID: NCT00973479
Completado
Fase 3
ClinicalTrials.gov
A Randomized Withdrawal Double-blind Study of Etanercept Monotherapy Compared to Methotrexate Monotherapy for Maintenance of Remission in Subjects With Rheumatoid Arthritis
INTERVENTIONAL
Inicio: 20 de feb de 2015
ID: NCT02373813
Terminado
Fase 3
ClinicalTrials.gov
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, 2-Stage Trial to Evaluate Efficacy and Safety of Telitacicept Compared to Placebo in Patients With Moderately to Severely Active Systemic Lupus Erythematosus (REMESLE-1)
INTERVENTIONAL
Inicio: 20 de jun de 2022
ID: NCT05306574
Terminado
Fase 3
ClinicalTrials.gov
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Sarilumab in Patients With Polymyalgia Rheumatica
INTERVENTIONAL
Inicio: 9 de oct de 2018
ID: NCT03600818
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Secukinumab to Demonstrate the Efficacy at 24 Weeks and to Assess the Long Term Safety, Tolerability and Efficacy up to 2 Years in Patients With Active Psoriatic Arthritis
INTERVENTIONAL
Inicio: 1 de sept de 2011
ID: NCT01392326
Reclutando
Fase 2
ClinicalTrials.gov
An Adaptive, Randomized, Double-blind, Dose Exploration, Parallel Group, Placebo Controlled, Multicenter Phase 2 Trial to Evaluate the Efficacy, Safety and Tolerability of LNP023 in Combination With Standard-of-care With and Without Oral Corticosteroids in Patients With Active Lupus Nephritis Class III-IV, +/- V
INTERVENTIONAL
Inicio: 10 de ago de 2022
ID: NCT05268289
Completado
Fase 3
ClinicalTrials.gov
A 52-week, Multicenter Study to Assess the Time Course of Response to Secukinumab on Joint Inflammation Using Power Doppler Ultrasonography in Patients With Active Psoriatic Arthritis
INTERVENTIONAL
Inicio: 22 de ago de 2016
ID: NCT02662985
Activo, no recluta
ClinicalTrials.gov
A Multicenter, Open Registry of Patients With Plaque Psoriasis Who Are Candidates for Systemic Therapy Including Biologics
OBSERVATIONAL
Inicio: 21 de jun de 2007
ID: NCT00508547
Anterior
1
...
15
16
17
...
434
Siguiente
Filtros